Beam Therapeutics, Inc. (BEAM)
22.85
-1.18
(-4.91%)
USD |
NASDAQ |
Nov 13, 16:00
22.99
+0.14
(+0.61%)
After-Hours: 19:59
Beam Therapeutics Price : 22.85 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 12, 2026 | 25.06 | 25.15 | 23.86 | 24.03 | 1.512M |
| Nov 11, 2026 | 25.47 | 26.07 | 24.67 | 25.81 | 1.584M |
| Nov 10, 2026 | 26.45 | 27.00 | 23.60 | 25.15 | 3.116M |
| Nov 09, 2026 | 26.79 | 27.39 | 25.96 | 27.02 | 1.292M |
| Nov 06, 2026 | 26.07 | 26.77 | 25.84 | 26.41 | 1.985M |
| Nov 05, 2026 | 27.36 | 27.48 | 24.88 | 25.87 | 2.991M |
| Nov 04, 2026 | 27.06 | 28.00 | 26.26 | 27.79 | 1.348M |
| Nov 03, 2026 | 26.26 | 27.20 | 25.99 | 26.33 | 1.434M |
| Nov 02, 2026 | 27.45 | 27.67 | 25.79 | 25.87 | 1.449M |
| Oct 30, 2026 | 28.27 | 28.85 | 26.43 | 27.23 | 1.500M |
| Oct 29, 2026 | 28.72 | 29.76 | 28.40 | 28.84 | 2.001M |
| Oct 28, 2026 | 24.61 | 28.86 | 24.50 | 28.78 | 5.008M |
| Oct 27, 2026 | 23.73 | 25.09 | 23.39 | 24.90 | 2.751M |
| Oct 26, 2026 | 24.00 | 24.11 | 23.65 | 23.79 | 1.401M |
| Oct 23, 2026 | 24.00 | 24.14 | 23.24 | 24.05 | 1.596M |
| Oct 22, 2026 | 24.38 | 25.29 | 24.00 | 24.56 | 1.385M |
| Oct 21, 2026 | 24.83 | 25.20 | 24.50 | 24.84 | 1.168M |
| Oct 20, 2026 | 24.00 | 25.06 | 23.61 | 24.93 | 1.480M |
| Oct 19, 2026 | 23.88 | 24.38 | 23.50 | 24.19 | 1.317M |
| Oct 16, 2026 | 24.56 | 24.56 | 23.16 | 23.47 | 1.653M |
| Oct 15, 2026 | 23.51 | 24.98 | 23.20 | 24.73 | 1.780M |
| Oct 14, 2026 | 24.13 | 24.26 | 23.28 | 23.65 | 1.662M |
| Oct 13, 2026 | 24.88 | 24.93 | 24.08 | 24.43 | 1.668M |
| Oct 12, 2026 | 25.63 | 26.09 | 24.94 | 25.13 | 1.414M |
| Oct 09, 2026 | 24.72 | 26.22 | 24.55 | 25.70 | 1.802M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Intellia Therapeutics, Inc. | 9.705 |
| Twist Bioscience Corp. | 111.56 |
| Prime Medicine, Inc. | 4.255 |
| Sarepta Therapeutics, Inc. | 16.06 |
| Q32 Bio, Inc. | 8.72 |
Price Related Metrics
| PS Ratio | 16.25 |
| Price to Book Value | 2.481 |
| Earnings Yield | -4.57% |
| Market Cap | 2.364B |